Investor Alert

New York Markets Open in:

March 11, 2021, 7:10 a.m. EST

Denmark pauses AstraZeneca jabs after blood clots

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Cecilia Butini

--Denmark pauses AstraZeneca vaccinations vaccine amid blood clot reports

--Connections between the vaccines and this side effect yet to be investigated by EU

--AstraZeneca confirmed the vaccine has generally been well tolerated in trials

The Danish health authority said Thursday that it will pause vaccinations with AstraZeneca PLC's coronavirus vaccine for 14 days after reports of cases of blood clots in those vaccinated.

"The Danish and European pharmaceutical authorities are keeping a close eye on the rollout of vaccines against Covid-19, both in terms of the more common mild side effects and the rare, but serious, possible side effects," the Danish authority said in a statement on its website.

It said the national board of health would wait for European Union drug authorities to investigate possible connections between AstraZeneca's vaccine and the reported blood clot cases.

"Patient Safety is the highest priority for AstraZeneca. Regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes Covid-19 Vaccine AstraZeneca," an AstraZeneca spokesman said.

They added that the safety of the vaccine has been studied extensively in Phase-3 trials, and that peer-reviewed data confirms the vaccine has been generally well tolerated.

Write to Cecilia Butini at cecilia.butini@wsj.com

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.